Merck & Co. (MRK) Divests Surface Solutions for 665 million

Merck & Co., Inc. (NYSE:MRK) is one of the best depressed stocks to buy in 2025. On August 2, the company completed the divestment of its Surface Solutions business to Global New Material International Holdings.

The sale follows regulatory approval and fulfillment of customary closing conditions. Merck & Co. is to receive €665 million from the transaction. It plans to use the net proceeds from the sale to strengthen its core strategic business. Part of the plan entails positioning the Electronics division more strongly to offer semiconductor solutions.

“With the completion of this transaction, we are focusing our portfolio even more clearly on technology-driven businesses,” said Belén Garijo, Chairwoman of the Executive Board and CEO of Merck. “Alongside acquisitions such as our recent purchases of SpringWorks Therapeutics, HUB Organoids, Unity-SC and Mirus Bio, the divestment of non-strategic businesses remains a key part of our M&A strategy, which is focused on long-term growth through innovation.”

Merck & Co., Inc. (NYSE:MRK) is a science and technology company that focuses on healthcare, life sciences, and electronics. It develops and manufactures products for various sectors, including pharmaceuticals, laboratory tools, and electronic materials.

While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 Medical AI Companies to Buy According to Analysts and 10 Best Rare Earth Stocks to Buy Now.

Disclosure: None. This article is originally published at Insider Monkey.